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Abstract
Our previous work in 293T cells and AF17
-/- mice suggests that AF17 upregulates expression and activity of the epithelial
Na
+ channel (ENaC), possibly by relieving Dot1a-AF9-mediated repression. However, whether and how AF17 directly
regulates Dot1a cellular distribution and ENaC function in renal collecting duct cells remain unaddressed. Here, we report
our findings in mouse cortical collecting duct M-1 cells that overexpression of AF17 led to preferential distribution of Dot1a
in the cytoplasm. This effect could be blocked by nuclear export inhibitor leptomycin B. siRNA-mediated depletion of AF17
caused nuclear accumulation of Dot1a. AF17 overexpression elicited multiple effects that are reminiscent of aldosterone
action. These effects include 1) increased mRNA and protein expression of the three ENaC subunits (a, b and c) and serum-
and glucocorticoid inducible kinase 1, as revealed by real-time RT-qPCR and immunoblotting analyses; 2) impaired Dot1a-
AF9 interaction and H3 K79 methylation at the aENaC promoter without affecting AF9 binding to the promoter, as
evidenced by chromatin immunoprecipitation; and 3) elevated ENaC-mediated Na
+ transport, as analyzed by measurement
of benzamil-sensitive intracellular [Na
+] and equivalent short circuit current using single-cell fluorescence imaging and an
epithelial Volt-ohmmeter, respectively. Knockdown of AF17 elicited opposite effects. However, combination of AF17
overexpression or depletion with aldosterone treatment did not cause an additive effect on mRNA expression of the ENaC
subunits. Taken together, we conclude that AF17 promotes Dot1a nuclear export and upregulates basal, but not
aldosterone-stimulated ENaC expression, leading to an increase in ENaC-mediated Na
+ transport in renal collecting duct
cells.
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Introduction
The primary function of the renal collecting duct is to adjust
the final urinary solute osmolarity and concentrations, and is
comprised of two functionally distinct epithelial cells: the
principal and intercalated cells [1]. The principal cells of the
cortical collecting duct contribute significantly to this process
[2,3]. Na
+ is reabsorbed from the renal ultrafiltrate through the
epithelial Na
+ channel (ENaC) and the Na
+/Cl
– cotransporter at
the apical side, and excreted at the basolateral membrane of the




absorption concurrent with the osmotic movement of water
increases extracellular fluid volume and consequently blood
pressure [4]. Many groups have studied the molecular mecha-
nisms governing ENaC trafficking, cell surface expression,
maturation, assembly, open probability, and degradation
[5,6,7,8,9]. For example, studies have shown that functional
ENaC is assembled from three structurally related subunits (a, b,
c) in the endoplasmic reticulum, where it is subject to N-linked
glycosylation [10,11,12]. The maturation of the channel requires
further posttranslational modifications on its passage through the
Golgi. These modifications include furin-mediated cleavage of a
and c subunits and the concurrent substitution of a high-mannose
glycosylation pattern for a complex one [13]. The glycosylation
and proteolytic processing of the ENaC channel are prerequisites
for full activity.
However, the mechanisms controlling ENaC transcription,
especially in the context of chromatin, are not well defined.
Aldosterone imposes tight and complex regulation on ENaC at
both transcriptional and posttranscriptional levels. The classical
mechanism of aldosterone action involves binding to the
cytoplasmic mineralocorticoid receptor (MR), which functions as
a ligand-dependent transcription factor. Upon binding of the
ligand, MR is translocated into the nucleus and stimulates
transcription by binding to the hormone response elements
present in the 59 flanking regions of target genes [14].
Nevertheless, how the ligand-bound MR gains access to DNA
that is packed into chromatin remains largely unknown.
PLoS ONE | www.plosone.org 1 November 2011 | Volume 6 | Issue 11 | e27429Using mouse inner medullary collecting duct mIMCD-3 cells
and kidneys isolated from Sgk1 WT and mutant mice, we have
previously found that disruptor of telomeric silencing alternative
splice variant a (Dot1a) [15] and ALL-1 fused gene from
chromosome 9 (AF9) [16] form a protein complex that represses
aENaC in an aldosterone-sensitive manner. Under basal condi-
tions, Dot1a-AF9 binds to the specific subregions of aENaC
promoter, promotes H3 K79 methylation, and inhibits transcrip-
tion [15,16]. Aldosterone relieves the repression by decreasing
mRNA expression of Dot1a and AF9, and by impairing Dot1a-
AF9 interaction through Sgk1-mediated AF9 phosphorylation at
Ser435 [17]. Hence, transcriptional activation of aENaC by
aldosterone can be partially attributed to induction of Sgk1 and
downregulation of Dot1a and AF9 mRNA expression.
Recently, we found that ALL-1 partner at 17q21 (AF17)
functions as a competitor of AF9 to bind the same domain of
Dot1a and enhances ENaC-mediated Na
+ transport in 293 cells
[18]. We also generated the first (to our knowledge) AF17
-/- mice
and identified their phenotype characterized by increased urinary
Na
+ excretion and decreased blood pressure [19]. While all of
these studies suggest the importance of AF17 in relieving Dot1a-
AF9-mediated repression of ENaC genes, and tuning ENaC-
mediated Na
+ transport and blood pressure, evidence demon-
strating that AF17 plays these roles in the renal collecting duct
cells, the physiological site of ENaC-mediated Na
+ transport in the
kidney, is still missing. In addition, the effect of AF17
overexpression on ENaC induction by aldosterone remains
unknown.
In this report, we primarily use mouse cortical collecting duct
M-1 cells as the model system to address these questions. We
found that AF17 promotes Dot1a cytoplasmic expression in a
leptomycin B (a nuclear export inhibitor)-sensitive manner, and
increases ENaC expression and activity in these more physiolog-
ically relevant cells.
Results
AF17 enhances Dot1a nuclear export in a leptomycin
B-sensitive manner in M-1 cells
To demonstrate the biological relevance of the Dot1a-AF17
interaction and to directly test the theory that AF17 facilitates
Dot1a nuclear export, we chose M-1 cells as the model system. M-
1 cells were derived from mouse cortical collecting duct, and are
frequently used for investigation of ENaC mRNA and protein
expression as well as on ENaC-mediated Na+ transport by many
groups and us [20,21,22,23]. Accordingly, M-1 cells were
cotransfected with two constructs expressing red fluorescence
protein-tagged (RFP)-hAF17 and GFP-Dot1a, treated with
methanol as vehicle control or leptomycin B (LMB, 10 nM) to
specifically inhibit CRM-1-mediated nuclear export. This con-
centration of LMB was selected because it has been shown to
inhibit nucleocytoplasmic shuttling of Id1 in human umbilical vein
endothelial cells [24]. The cellular distribution of GFP-Dot1a and
RFP-hAF17 was then determined by deconvolution microscopy.
In the absence of LMB, GFP-Dot1a and RFP-hAF17 were
primarily, if not exclusively, located in the cytoplasm and
colocalized (Fig. 1A, top panel). The typical nuclear distribution
pattern of GFP-Dot1a when expressed alone or in combination
with RFP-AF9 is large discrete foci throughout the nucleus [16].
This pattern was hardly found in these methanol-treated cells.
However, addition of LMB promoted the typical nuclear
distribution of Dot1a. Furthermore, the majority of RFP-hAF17
also resided in the nuclei and colocalized with GFP-Dot1a (Fig 1A,
bottom panel).
To more accurately assess the effects of AF17 overexpression
and LMB on Dot1a cellular distribution, the cotransfected cells
were divided into three categories based on the cellular
distribution of RFP-hAF17 and GFP-Dot1a. Unlike the two types
mentioned above, the third type of expression pattern was seen in
cells that displayed substantial signals in both the cytoplasm and
the nucleus. Without LMB, the two fusion proteins resided in the
cytoplasm in about 55% of cells. Their nuclear expression was
observed in only 16% of cells. The remaining 29% of cells
displayed substantial GFP-Dot1a and RFP-hAF17 in both of the
cytoplasm and nucleus (Fig. 1B). In the presence of LMB, the
percentage of the cytoplasmic pattern was reduced from 55% to
only 6% of cells. In contrast, the percentage of the cells displaying
Dot1a and AF17 nuclear expression was increased from 16% to
77% (Fig. 1B). These observations suggest that overexpression of
RFP-hAF17 and GFP-Dot1a leads to preferential shift of both
proteins from the nucleus to the cytoplasm, most likely through
mechanisms involving CRM-1-mediated nuclear export that can
be blocked by LMB.
SinceGFPorRFPmayalterthe subcellularlocalizationoftagged
proteins, we examined the effect of WT Dot1a on RFP-hAF17
localization and reciprocally the effect of hAF17 on GFP-Dot1a
localization. Overexpression of WT Dot1a had marginal effect on
RFP-hAF17 cellular distribution as evidenced by no significant
differences in each category between Vec- and Dot1a-transfected
cells (Fig. S1A). In contrast, the cellular distribution of GFP-Dot1a
was significantly impacted by coexpression of WT hAF17, with
cytoplasmic expression being increased from ,10% to ,50% and
nuclear expression reduced from ,70% to ,22% (Fig. S1B).
In reciprocal experiments, we applied RNA interference
technology to deplete the endogenous AF17 and examined the
effects on the cellular distribution of GFP-Dot1a. Two siRNA
constructs specifically targeting AF17 and a negative control
construct were transfected into M-1 cells to establish stable cell
lines. No adverse effects on cell growth or morphology were
observed in any of the siRNA-transfected cell lines. Real-time RT-
qPCR showed that siRNA#10 and siRNA#11 knocked down
AF17 mRNA levels to 53% and 31%, respectively, compared with
the control cell line transfected with the negative control construct
harboring an unrelated siRNA target sequence (Fig. 2A). Since
siRNA#11-transfected cells had more efficiently depleted AF17
expression, these cells along with the control cell line were
transiently transfected with the GFP-Dot1a construct. In the
control cell line, GFP-Dot1a displayed the cytoplasmic expression
pattern in 51% of cells, with 22% of cells expressing GFP-Dot1a in
the nucleus or 27% of cells in both of the compartments. In the
siRNA#11-transfected cells, these numbers were significantly
changed into 28%, 58% and 14%, respectively (Fig. 2B and 2C).
In brief, our data are consistent with the notion that AF17
promotes distribution of Dot1a from the nucleus to the cytoplasm,
most likely through CRM-1-mediated nuclear export pathway.
AF17 overexpression impairs H3 K79 methylation at the
aENaC promoter in M-1 cells
We previously demonstrated that the Dot1a-AF9 complex is
associated with specific subregions of the aENaC promoter and
promotes H3 K79 hypermethylation at these subregions in
mIMCD-3 cells [15,16,17]. Given the facts that AF17 facilitates
Dot1a nuclear export (Fig. 1 and 2), we intended to determine if
AF17-mediated downregulation of Dot1a nuclear expression is
coupled to changes in Dot1a-AF9 interaction and H3 K79
methylation associated with the aENaC promoter. M-1 cells were
transiently transfected with pFLAG-AF9 (to determine AF9
binding and its interaction with Dot1a at the promoter) along
AF17 Increases Basal ENaC Expression and Activity
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incubation with LMB or methanol as vehicle control. The
resulting four groups of cells were then analyzed by chromatin
immunoprecipitation coupled real-time qPCR (ChIP-qPCR) with
specific primers for amplification of the five subregions of the
aENaC promoter (Fig. 3A).
ChIP with antibodies against Dot1a or H3 me2K79 revealed
relatively higher levels of Dot1a, and thus elevated H3 me2K79
associated with R1-R3, as compared to Ra and R0 subregions in all
groups (Fig. 3B and 3C), similar to what we reported in mIMCD-3
cells [17]. AF17 overexpression significantly decreased the associ-
ation of Dot1a and thus H3 me2K79 with R1-R3 to various
degrees, compared to those in the vector-transfected cells (Fig. 3B
and 3C) in the absenceor presence of LMB. These data suggest that
AF17 regulates Dot1a and H3 me2K79 at the aENaC promoter in
M-1 cells. Taken together with the subcellular localization data
(Fig. 1 and 2), we speculate two mechanisms. Without inhibition of
nuclear export by LMB, overexpressed AF17 may promote Dot1a
nuclear export, leading to impairment of nuclear-located and thus
promoter-associated H3 K79 methylation. Addition of LMB may
cause the majority of overexpressed AF17 and Dot1a located in the
nucleuswhereAF17inhibitsDot1a-AF9interactionatthepromoter
(Fig. 3 D and E, see below).
To directly test the hypothesis that AF17 overexpression inhibits
Dot1a-AF9 interaction at the aENaC promoter, ChIP with anti-
FLAG was performed. Interaction of AF9 with R0-R3, but not
with Ra, was detected. Within each of the subregions, the four
groups of cells were indistinguishable in terms of AF9 binding
(Fig. 3D). However, sequential ChIP first with the anti-FLAG
antibody coupled with an anti-Dot1a antibody (Re-ChIP) revealed
that AF17 overexpression significantly impaired the Dot1a-AF9
interaction at all of the four subregions (R0-R3), regardless of the
LMB treatment (Fig. 3E). Therefore, like aldosterone-induced
Sgk1 [17], AF17 appears to regulate the Dot1a-AF9 interaction at
the promoter without measurably affecting the association of AF9
with the promoter.
AF17 expression is not regulated by aldosterone in M-1
and mIMCD-3 cells
We have reported that aldosterone downregulates mRNA
expression of Dot1a and AF9 in mIMCD-3 cells. However, the
Figure 1. Inhibition of nuclear export by LMB promotes nuclear accumulation and cytoplasmic depletion of Dot1a-AF17 complex in
M-1 cells. A. Representative deconvolution microscopy images show cytoplasmic or nuclear colocalization of transiently expressed GFP-Dot1a and
RFP-hAF17 in the absence (top panel) or presence (low panel) of LMB (10 nM) in M-1 cells. Original amplification: X400. Note: Dot1a in the low panel
exhibited the typical nuclear distribution pattern characterized by large discrete foci. B. The bar graph shows that LMB causes preferential expression
of Dot1a and AF17 in the nucleus. As in A except for that cells expressing both of GFP-Dot1a and RFP-AF17 were examined by epifluorescence
microscopy and categorized as cytoplasmic (C), nuclear (N), or both (C/N) depending on the location of the fusion proteins. The graphed value (%) is
the number of cells of each localization type divided by the total number of cells examined. At least 250 cotransfected cells were examined from
three independent experiments (n=3). Each percentage was compared with control (-LMB) within the category. n=3.*:p,0.05.
doi:10.1371/journal.pone.0027429.g001
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in mIMCD-3 cells remains unknown. Accordingly, real-time RT-
qPCR of M-1 cells treated with aldosterone (1 mM for 24 h) or
vehicle was conducted. ENaC, Dot1a and AF9 genes were
included as controls of aldosterone-upregulated and -downregu-
lated genes, respectively. As expected, aldosterone significantly
stimulated mRNA expression of the three ENaC genes, with their
mRNA levels being elevated to 410%, 256%, and 187% of
control, respectively (Fig. S2A). Dot1a and AF9 mRNA levels were
significantly lowered to 19% and 25% of control by aldosterone
treatment (Fig. S2B). However, no significant alteration in AF17
mRNA abundance was seen (Fig. S2B).
In parallel experiments, mIMCD-3 cells were treated with
aldosterone (1 mM for 24 h) or vehicle, and analyzed by RT-
qPCR. While aldosterone significantly increased ENaC expression
at both mRNA and protein levels [23], and decreased Dot1a and
AF9 mRNA levels ([15,16] and Fig. S2C), it failed to substantially
affect AF17 mRNA expression (Fig. S2C). We conclude that AF17
is most likely not regulated by aldosterone at the transcriptional
level in M-1 and mIMCD-3 cells under the conditions tested.
AF17 plays a redundant role with aldosterone in
upregulating aENaC expression in M-1 cells
Since AF17 impairs Dot1a-AF9 interaction and H3 K79
methylation at the aENaC promoter, we anticipate that AF17,
like aldosterone, relieves Dot1a-mediated repression of the aENaC
promoter in M-1 cells. To test this hypothesis, M-1 cells were
transiently transfected with pcDNA3.1, pcDNA-Dot1a, or
pcDNA-AF17 along with an aENaC promoter luciferase construct,
and examined by real-time RT-qPCR and luciferase assay. b-actin
was used as an internal control in RT-qPCR. aENaC mRNA was
,32%, 230%, or 175% of the control in cells overexpressing
Dot1a, AF17, or both, respectively (Fig. 4A). A similar pattern was
obtained for the expression of the luciferase reporter (Fig. 4B).
In reciprocal experiments, we examined the effects of AF17
depletion on the activity of the aENaC promoter. AF17 knockdown
in siRNA#10- and siRNA#11-transfected M-1 cells was accom-
panied with a reduction of aENaC mRNA levels to 39% and 31% of
control, respectively (Fig. 2A and 4C). Similarly, the luciferase
reporter activity was also significantly lowered in these cells,
compared to control (Fig. 4D). Consistently, aENaC expression at
Figure 2. Depletion of AF17 enhances nuclear distribution of Dot1a in M-1 cells. A. M-1 cells were stably transfected with pSilencer-2.1-U6-
Hygro vector (Vec) or its derivatives bearing AF17-specific siRNA#10 or siRNA#11. Total RNA was analyzed by real-time RT-qPCR for AF17 expression.
B-C. M-1 cells stably transfected with the vector or siRNA#11 as shown in A were transiently transfected with pGFP-Dot1a and analyzed by
deconvolution microscopy as in Fig. 1A (B) or epifluorescence microscopy as in Fig. 1B (C). Original amplification: X400. n=3.*:p,0.05 vs. vector in
each category.
doi:10.1371/journal.pone.0027429.g002
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downregulated by AF17 knockdown (see below).
To investigate the effect of AF17 overexpression on the
aldosterone-induction of aENaC mRNA expression, M-1 cells
were stably transfected with pCDNA3.1 (Vec) or pCDNA-hAF17
(AF17). These stable cells were treated with aldosterone (1 mM for
24 h) or vehicle and analyzed by RT-qPCR. The aENaC mRNA
levels was significantly elevated to 430% and 310% of the control
(vehicle-treated, Vec-transfected cells) by aldosterone and AF17
overexpression, respectively (Fig. 4D). However, the effect of AF17
overexpression on the aldosterone-induction of aENaC mRNA
expression was marginal, because aENaC mRNA level was only
further increased to 480% of control) in the AF17-overexpressing,
aldosterone-treated cells (Fig. 4D). Knockdown of AF17 also had
subtle effect on aENaC induction by aldosterone (Fig. 4E). Similar
results were obtained when b and cENaC mRNA levels were
examined in parallel (Fig. S3A and S3B). In brief, aldosterone and
AF17 may play a redundant role in regulating mRNA expression
of the ENaC subunits.
AF17 regulates several other aldosterone target genes in
M-1 cells
To determine if AF17 plays a role in the transcriptional control
of other aldosterone target genes in M-1 cells, we used RT-qPCR
to analyze bENaC, cENaC, Sgk1, MR, CTGF, preproendoethelin-1, and
period, all except MR had significantly increased mRNA expression
due to AF17 overexpression to various degrees (Fig. 5A-C).
To determine whether AF17-mediated transcriptional alteration
of these target genes is translated into corresponding changes in
their protein abundance, immunoblotting analyses were per-
Figure 3. AF17 impairs Dot1a-AF9 interaction and H3 K79 methylation at the aENaC promoter in M-1 cells. A. Diagram of the aENaC
promoter [17]. B-E. Chromatin immunoprecipitation (ChIP) and sequential ChIP (Re-ChIP) assays demonstrating that overexpression of AF17
differentially affected the abundance of Dot1a (B), H3 dimethylated K79 (H3 me2K79) (C), FLAG-AF9 (D), and FLAG-AF9 interaction with Dot1a (E)a t
the aENaC promoter. M-1 cells were transiently transfected with pFLAG-AF9 along with pcDNA3.1 (Vec) or pcDNA-AF17 (AF17). 6 h later, the cells
were treated with vehicle or LMB (10 nM) for an additional 16 h. Chromatin was immunoprecipitated by the antibodies as indicated, followed by real-
time qPCR with primers amplifying Ra and R0-R3 subregions of the aENaC promoter as shown in A. For Re-ChIP, chromatin was sequentially
immunoprecipitated with anti-FLAG and anti-Dot1a antibodies. Relative ChIP or Re-ChIP efficiency was defined as the (re-) immunoprecipitated
amount of materials present as compared to that of the initial input sample, and set to 1 in R0 from the Vec-transfected cells treated with vehicle, and
was calculated accordingly for all other samples. *: P,0.05 vs. Vec within the same subregion for the same treatment. n=3–4 for all panels.
doi:10.1371/journal.pone.0027429.g003
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bENaC, cENaC, and Sgk1 were 2–4 fold higher in the AF17-
overexpressing cells than in the control.
Since AF17 mRNA was more effectively depleted in
siRNA#11-transfected cells, we used these cells to determine if
AF17 knockdown yields an opposite effect on expression of these
aldosterone target genes. As expected, a significant reduction in
the mRNA levels of bENaC, cENaC, Sgk1, CTGF, preproen-
doethelin-1, and period was found in siRNA#11-transfected cells,
as compared to the control (Fig. 6A-C). AF17 depletion had little
Figure 4. AF17 upregulates basal, but not aldosterone-stimulated expression of aENaC in M-1 cells. A-B. AF17 overexpression increases
basal aENaC transcription. M-1 cells were transiently transfected with pGL3Zeocin-1.3-aENaC along with pcDNA3.1 (Vec) or its derivatives expressing
Dot1a or AF17. The total amount of plasmid DNA was kept constant for all transfections. Total RNA was analyzed for aENaC and actin expression by
real-time RT-qPCR. *P,0.05. n=3 (A). Alternatively, whole cell lysates were prepared and luciferase reporter assays were performed. *P,0.05 vs. Vec.
n=4(B). C-D. Knockdown of AF17 mRNA expression decreases basal aENaC transcription. M-1 cells were stably transfected with pSilencer-2.1-U6-
Hygro vector (Vec) or its derivatives bearing AF17-specific siRNA#10 or siRNA#11. Total RNA was analyzed by real-time RT-qPCR for AF17 (see Fig.
2A) or aENaC (C)a si nA, and whole cell lysates were examined by luciferase assays (D)a si nB. In all cases, n=3. *: P,0.05 vs. vector. E-F. AF17
overexpression or knockdown had marginal effects on the aldosterone-mediated induction of aENaC expression. Stably transfected M-1 cells
overexpressing AF17 (see Fig. 8A) or depleting AF17 (see Fig. 2A) were treated with ethanol as vehicle control (-Aldo) or aldosterone (+Aldo, 1 mM),
and analyzed by RT-qPCR for aENaC as in A. In all cases, n=3. *: P,0.05 vs. vector.
doi:10.1371/journal.pone.0027429.g004
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mRNA expression was followed by a decrease of the protein
abundance of each corresponding gene examined (Fig 6D).
AF17 enhances benzamil-sensitive Na
+ transport in M-1
cells
To determine if AF17-mediated regulation of mRNA and
protein expression of ENaC genes is physiologically coupled to
ENaC activity, we performed SBFI-AM-based single cell fluores-
cence imaging to measure intracellular [Na
+] ([Na
+]i). M-1 cells
were transiently transfected with RFP as vector control or RFP-
hAF17. Transfected cells were identified by epifluorescence
microscopy and subjected to measurement of [Na
+]i. Represen-
tative tracings of the two transfections are given in Fig. 7A-B,
respectively. The basal level of [Na
+]i (in mM, the same below) was
decreased from 16.5 to 6.23 by addition of benzamil in vector-
transfected cells, suggesting that ENaC is primarily responsible for
Na
+ transport in this cell line. These figures became 24.7 and 8.2,
respectively, in AF17-overexpressing cells (Fig. 7C). Therefore, the
corresponding benzamil-sensitive [Na
+]i was significantly elevated
from 10.3 to 16.5 by AF17 overexpression (Fig. 7D).
Measurement of the equivalent short circuit current (Isc) was
carried out to independently confirm these results. M-1 cells were
stably transfected with pCDNA3.1 or pCDNA-hAF17. To
determine whether the cells cultured on permeable supports
express hAF17, primers were designed to specifically amplify
hAF17, but not the endogenous mouse Af17. hAF17 was readily
detectable in the pCDNA3.1-hAF17 transfected cells, and
undetectable in the pCDNA3.1-transfected cells, as evidenced by
DNA agarose gel analysis of RT-PCR with these hAF17-specific
primers (Fig. 8A). Similar to previous findings (Helms et al, 2003),
these two cell lines developed comparably high transepithelial
resistance (1001 vs. 1150 V.cm
2) (Fig. S4). In the absence of
benzamil, Isc (in mA/cm
2) was 4.5 or 7.8 in the vector-transfected
or AF17-overexpressing cells, respectively. Addition of benzamil
dramatically inhibited Isc to 1.8 and 2.7 (Fig. 8B), suggesting that
ENaC is the primary, if not exclusive, target in AF17-mediated
regulation of Na
+ transport in M-1 cells. It should be noted that
our measurements of transepithelial resistance and Isc are
comparable to those measured for M-1 cells by others (Helms et
al, 2003). Collectively, the data consistently indicate that AF17
impairs Dot1a-AF9 mediated suppression of ENaC transcription,
Figure 5. Overexpression of AF17 increases mRNA and protein expression of ENaC and Sgk1 in M-1 cells. M-1 cells were transiently
transfected with pcDNA3.1 (Vec) or pcDNA-AF17 (AF17), and analyzed by RT-qPCR as in Fig. 4A. Shown are bENaC and cENaC (A), ENaC regulators
Sgk1 and MR (B), three other aldosterone target genes: CTGF, preproendothelin-1, and period (C). In D, whole cell lysate was analyzed by
immunoblotting with antibodies against the proteins indicated. The relative abundance of mRNA or protein of each gene was set to 1 or 100,
respectively, in vector-transfected cells, and used for comparison. n=3. *: P,0.05 vs. Vector (Vec) for each gene.
doi:10.1371/journal.pone.0027429.g005
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subsequent ENaC activity.
Discussion
Our earlier work, primarily done in mIMCD-3 cells, led to
identification and characterization of an aldosterone-signaling
network controlling aENaC transcription [15,16,17]. The network
involves Dot1a, AF9, and Sgk1. Recently, we added AF17 into this
network, characterized its role first in vitro in 293T cells [18] and
then in vivo in mouse kidney [19]. While 293T cells provide
practical advantages in transient transfection studies of heterolo-
gous genes in a kidney epithelial cell type, they are not specifically
generated from the renal collecting duct, where ENaC-mediated
physiological Na
+ transport in the kidney occurs. Analyses of
kidneys from both WT and AF17
-/- mice provided strong evidence
of AF17 involvement in Na
+ metabolism and blood pressure
control. Nevertheless, the complexity of the whole animal context
and heterogeneous cellular composition of the kidney makes it
impractical to obtain direct evidence showing the function and
regulation of AF17 in renal collecting duct. Therefore, in this
report, we pursue to define AF17 role in a more homogenous,
physiologically relevant system: M-1 cells.
The M-1 cells were derived from renal cortical collecting duct
(CCD) micro-dissected from a transgenic mouse carrying the early
region of SV40 virus [25]. The CCD is characterized by
expression of CCD-specific antigens, a high transepithelial
electrical resistance, a luminal-negative transepithelial potential
difference, ion transport primarily through ENaC-mediated Na+
transport that can be blocked by amiloride, and responsiveness to
aldosterone and arginine vasopressin [25]. These features are
apparently maintained in M-1 cells [25]. With multiple approach-
es, we solidify the notion of AF17 as a regulator of Dot1a nuclear/
cytoplasmic distribution, ENaC expression, and ENaC-mediated
Na
+ absorption in mammalian collecting duct cells. In particular,
we provide the first line of evidence suggesting that M-1 cells may
share the same mechanisms with mIMCD-3 cells to control
aENaC transcription through Dot1-AF9-AF17-mediated H3 K79
methylation.
AF17 and Sgk1 share some functional aspects. In particular,
they regulate aENaC transcription at least in part by modulating
H3 K79 methylation at the aENaC promoter. ChIP and Re-ChIP
demonstrate that in the absence of LMB, the association of Dot1a
with R1-R3 subregions of aENaC promoter was 48% to 65%
lower than control in AF17 overexpressing cells. The decreased
Dot1a binding was followed by a reduction of 60% to 80% in H3
Figure 6. Knockdown of AF17 decreases mRNA and protein expression of ENaC and Sgk1 in M-1 cells. M-1 cells were stably transfected
with pSilencer-2.1-U6-Hygro vector (Vec) or its derivative bearing AF17-specific siRNA#11, and analyzed by RT-qPCR (A-C) or immunoblotting (D)a s
in Fig. 5. n=3. *: P,0.05 vs. Vector (Vec) for each gene.
doi:10.1371/journal.pone.0027429.g006
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pression were not generally affected by LMB. In all cases, AF9
binding to the promoter was not significantly impaired. These
observations are reminiscent of what we observed in mIMCD-3
cells when Sgk1 was overexpressed [17].
However, AF17 and Sgk1 differ in their mechanisms. First,
AF17 impairs Dot1a-AF9 interaction by competing with AF9 for
the same binding domain within Dot1a [18]. Sgk1 attenuates
Dot1a-AF9 complex formation by decreasing AF9 ability to
interact with Dot1a through phosphorylating AF9 Ser435 [17];
Secondly, AF17 association with the aENaC promoter has not
been established because of the difficulties in detecting AF17 in
immuoprecipitation/immunoblotting analyses as we discussed in
detail before [18]. Whether AF17 regulates the promoter-bound
or promoter-free Dot1-AF9 complex remains to be defined. In
contrast, Sgk1 is shown to bind aENaC promoter [17]. Its
interference with Dot1a-AF9 interaction can presumably occur
even at the aENaC promoter; Thirdly, AF17 mRNA expression is
not likely to be regulated by aldosterone, at least in the three cell
lines examined (293T, M-1, and mIMCD-3) under the conditions
tested (1 mM for 24 hr), while Sgk1 is rapidly and persistently
induced by aldosterone [17,26]; Fourthly, AF17 regulates Sgk1
mRNA and protein expression (Fig. 5B & D). Given the fact that
Sgk1 is involved in many signaling pathways, and its expression
can be induced by multiple stimuli [27], it can be postulated that
AF17 may also play a role in these signaling pathways and
functions upstream of Sgk1. It can be speculated that AF17
relieves Dot1a-AF9 repression not only by competing with AF9 to
bind Dot1a, but also through increasing Sgk1 expression to
enhance Sgk1-mediated AF9 phosphorylation. Future studies are
needed to address the later possibility.
Previous studies from different groups suggest that aldosterone
regulate ENaC expression in a subunit- and tissue-specific
manner. Classically, aldosterone does not stimulate b and cENaC
expression in the renal cortical collecting duct (reviewed in [28]).
For example, elevated circulating aldosterone as a result of either
dietary NaCl restriction or aldosterone infusion selectively
increased aENaC protein abundance without increasing the levels
of the b and c subunits in rat kidney [29]. This pattern was
changed in the colon, where b and c ENaC mRNA levels were
elevated by aldosterone administration while aENaC was














































































Figure 7. Overexpression oAF17 enhances extracellular [Na
+]i in M-1 cells. A-B. Shown are representative SBFI recordings of M-1 cells
transiently transfected with red fluorescence protein vector RFP (Vec) or RFP-AF17. The cells were analyzed for Na
+ transport. Transfected cells were
first identified and marked by epifluorescence microscopy with an RFP-specific filter. The same field of cells was then switched to SBFI-specific filters
for [Na
+]i imaging. C-D. Shown are the averages of [Na
+]i before (-Ben) and after (+Ben) 1 mM benzamil addition (C) and benzamil-sensitive [Na
+]i (D)
from at least 25 transfected cells per transfection from three independent experiments. Readings of non-transfected cells were excluded from
analysis. In all cases, *: P,0.05 vs. Vec. n=3.
doi:10.1371/journal.pone.0027429.g007
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significantly increased a and cENaC expression at both mRNA
and protein levels, whereas had little impact on bENaC expression
[33]. In the wild type or protein kinase D1-depleted M-1 cells,
aldosterone (10 nM, 4hr) did not significantly alter bENaC protein
expression [20]. In the A6 cells, which are believed to have similar
signal transduction and electrophysiological properties to those of
mammalian collecting duct principal cells, aldosterone (100 nM,
3h or 6h) stimulated mRNA synthesis of a and c, but not b
subunit. However, at the protein level, only a and b subunits were
increased by the aldosterone treatment at these time points [34].
This result differs from those reported by others in the A6 cells.
For instance, b but not a and cENaC protein levels were
reproducibly increased in response to long-term administration of
aldosterone (1.5 mM; $72 h) [35]. In another study with the A6
cells, aldosterone (300 nM, 24 h) was shown to increase mRNA
abundance of the three ENaC subunits [36]. The induction of the
a, b and cENaC by aldosterone (1 mM, 24 h) was also observed in
293T and mIMCD3 cells in our previous studies [18,23] and in
M-1 cells in the current study (Fig. 4 and S3). It can be speculated
that multiple factors may contribute to the inconsistent observa-
tions described above. These factors include the homogeneity/
heterogeneity of the cell population involved, and the doses and
time points of aldosterone treatment. It also should be noted that
Figure 8. AF17 enhances benzamil-sensitive equivalent short-circuit current (Isc) in M-1 cells. A. Representative agarose gel analyses of
hAF17 expression in M-1 cells stably transfected with pCDNA3.1 (Vec) or pcDNA-hAF17. Cells were grown on permeable filters and allowed to form
confluent monolayers. Total RNA was prepared and examined by RT-PCR with primers specific for hAF17, followed by agarose gel analysis. B-C. As in
A, shown are averages of Isc before (-Benzamil) and after (+Benzamil) addition of 1 mM benzamil (B), or benzamil-sensitive Isc (DIsc; C). *P,0.05 vs. Vec.
n=12 or 15 for each cell population, respectively. D-E. Results are as in B-C except for that M-1 cells stably depleting AF17 as shown in Fig. 2A were
used. *P,0.05 vs. Vec. n=14 and 17, respectively.
doi:10.1371/journal.pone.0027429.g008
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aldosterone, particularly at high concentrations (such as 1 mM),
remain to be defined.
Materials and Methods
Rabbit polyclonal antibodies specific for ENaC subunits a, b, c,
Dot1a, FLAG, and Sgk1 as well as the plasmids expressing
untagged Dot1a and AF17 (pcDNA-Dot1a and pcDNA-hAF17),
green or red fluorescence-tagged Dot1a (GFP-Dot1a and RFP-
hAF17), AF17-specific siRNA#10 or siRNA#11 have been
described in our previous reports [15,16,17,18,23]. All chemicals
including benzamil, nigericin, monensin, benzofuran isophthalate
acetoxymethyl ester (SBFI-AM) and aldosterone were purchased
from Sigma (St. Louis, MO, USA).
Cell culture, transient and stable transfection and
aldosterone treatment
mIMCD-3 and M-1 cells (American Type Culture Collection,
Manassas, VA, USA) were grown in DMEM/F12 plus 10% FBS.
Cells were seeded in DMEM/F12 plus 10% charcoal-stripped
FBS for at least 50 hours, followed by addition of 1 mM
aldosterone or 0.01% ethanol as vehicle control for 24 h.
LIPOFECTAMINE
TM 2000 reagent (Invitrogen) was routinely
used for transient transfection. To deplete AF17 mRNA levels by
RNA interference, M-1 and mIMCD-3 cells were transfected by
siRNA#10, siRNA#11, and the parent vector pSilencer-2.1-U6-
Hygro as a negative control, and selected by hygromycin (500 g/
ml) treatment for about 2 weeks. All surviving colonies from the
same transfection were combined and expanded to establish the
corresponding cell lines. Parent cells were treated with hygromycin
similarly in parallel to assess the selection efficiency. Cells were
cultured on plates for real-time RT-qPCR and immunoblotting,
on cover slips for measurement of intracellular Na
+ concentration
([Na




Single-cell fluorescence imaging using Na
+ indicator SBFI-AM
was conducted to determine the intracellular sodium ion
concentration ([Na
+]i), as described by others [37,38,39] and us
[23]. Briefly, cells transiently transfected with RFP or RFP-AF17
fusion constructs were first identified and selected under
epifluorescence microscopy with a filter combination specific for
RFP. These cells were then used for collecting SBFI image data
under a separate filter combination. In all cases, data from
multiple cells in each experiment were represented by the average
and counted as a single observation (n=1). The bath temperature
was maintained at 37uC throughout the experiments.
To calibrate the intracellular SBFI-AM dye fluorescence,
ionophores (5 mM nigericin + 5 mM monensin) were used to
permeabilize the cell membrane and equilibrate [Na
+]i with bath
[Na
+] ranging from 0 to 140 mM [23,40]. Calibration curves were
generated using non-linear least small squares regression [41].
Isc measurement
Cells grown on 12-mm filter units were fed on both apical and
basolateral sides with culture medium (DMEM/F12 plus 10%
FBS) and allowed to form monolayers. The medium was replaced
every 3 days. An Epithelial Volt-ohmmeter (EVOM) (World
Precision Instruments) with a set of Ag:AgCl electrodes was used to
regularly monitor the transepithelial voltage (VTE) and transepi-
thelial resistance (RTE) of each filter under sterile conditions as
reported by others (17, 19) and us [23]. Monolayers with the
resistance $900 V?cm
2 were considered confluent (17) and used to
measure VTE every 1 min for minimal 10 times. Benzamil (1 mM)
was then added to the apical side. Five minutes later, VTE was
determined again similarly. The readings before or after benzamil
administration from a single filter were averaged and counted as 1
(n=1). The benzamil-sensitive equivalent Isc was determined as
the current difference with and without benzamil in the apical
bathing solution.
Epifluorescence and deconvolution microscopy
Cells grown on coverslips were transfected with the plasmids as
indicated in figure legends, using Lipofectamine 2000 (Invitrogen).
24 h later, cells were rinsed in phosphate buffered saline, fixed
with 1% fresh prepared paraformaldehyde for 30 minute, and
stained with 300 nM 40,6-diamidino-2-phenylindole (DAPI,
Sigma) for 15 min. All of these steps were done at room
temperature. Coverslips were mounted onto microscope slides
with Vectashield mounting medium (Vector Laboratories), and
examined either by epifluorescence or deconvolution microscopy.
Cells expressing GFP-Dot1a and RFP-AF17 (Fig. 1), or GFP-
Dot1a alone (Fig. 2) were categorized as cytoplasmic [C], nuclear
[N], or both [C/N], depending on the primary location of the
fusion proteins detected by epifluorescence microscopy [18,42]. It
should be pointed out that cells considered as C do not necessarily
indicate that the fusion proteins are exclusively located in the
cytoplasm. Nevertheless, it does mean that the vast majority of the
fusion proteins are located in the cytoplasm. This rule is also
applied to N. We then randomly selected multiple fields of each
transfection and took images with a deconvolution microscope to
confirm the distribution pattern. Deconvolution microscopy was
performed at the Multi-User Fluorescence Imaging and Micros-
copy Core Facility, Department of Pathology and Laboratory
Medicine, University of Texas Medical School, Houston, TX. The
protocols for image analysis were detailed in our earlier
publications [16,43]. Both epifluorescence microscopy and
deconvolution microscopy yielded consistent results in most cases.
This may explain why many other groups have used epifluores-
cence microscopy for similar experiments [44,45,46].
ChIP, real-time qPCR, or RT-qPCR
ChIP assays were performed as detailed previously [15] with the
sonication setting (3610 s, duty cycle: 50% and output control: 6)
using a Sonifier Cell Disruptor 350 (Branson). Gradient annealing
temperatures were employed to optimize the PCR conditions for
each primer pairs, generating a single sharp band with correct size
revealed by agarose gel. Real-time qPCRs were assembled with
SYBR Green Supermix (Bio-Rad) and conducted on a DNA
Engine Opticon System 2 (MJ Research). Each sample was
analyzed in triplicate. Serially diluted input DNA derived from a
mixture of all samples was used as a positive control and assigned
an arbitrary copy number to generate a standard curve for each
pair of primers at a fixed threshold cycle detection level. The copy
number of each test sample was then automatically calculated
according to its threshold cycle value, measured from cycle-
dependent product amplification curves. The relative binding of
each protein at each region was calculated by measuring the
apparent immunoprecipitation efficiency (the ratio of the copy
number of the ChIP sample to that of the corresponding input)
[15,47]. For each ChIP, the input contained 3% of the start
material. For real-time RT-qPCR, elimination of potential
genomic contamination was conducted by pretreatment of total
RNA samples with DNase I and verified by RT-PCR in which the
reverse transcriptase was omitted (data not shown). cDNA was
then synthesized with iScript cDNA Synthesis kit (Bio-Rad) and
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in the figure legends in separate wells. The copy number of each
transcript was normalized to that of actin and/or GAPDH from
the same sample. The sequences of all primers and the detailed
PCR conditions are available from the authors upon request. All
experiments were replicated a minimum of three times, with each
independent observation representing a single n in the figure
legends. The triplicates in RT-qPCR or qPCR experiments were
counted as a single n because they were derived from a single
sample, and their average was used to represent the corresponding
sample.
Luciferase and immunoblotting analyses
These assays are routinely used and were conducted according
to our published protocols [15,16,17].
Statistical analysis
All quantitative data shown are mean6SEM. For all compar-
isons, unpaired Student t-test was performed as reported by others
and us [16,17,34,38]. P,0.05 is considered as significant.
Supporting Information
Figure S1 Overexpression of WT AF17 affects the
cellular distribution of GFP-Dot1a. A. M-1 cells were
transiently transfected with RFP-hAF17 along with pcDNA3.1
(Vec) or its derivative encoding Dot1a, examined with epifluor-
escence microscopy, and categorized as cytoplasmic (C), nuclear
(N), or both (C/N) depending on the location of RFP-hAF17. The
graphed value (%) is the number of cells of each localization type
divided by the total number of cells examined. At least 200
cotransfected cells were examined from three independent
experiments (n=3). Each percentage was compared within the
same category within the category. n=3. No significance was
detected at p,0.05. B. As in A except plasmids expressing WT
hAF17 and GFP-Dot1a were used for transfection. *: p,0.05.
(EPS)
Figure S2 Aldosterone does not affect AF17 mRNA
expression in M-1 and mIMCD-3 cells. A-B. Total RNA
was isolated from M-1 cells cultured in DMEM plus 10%
charcoal-stripped FBS for at least 50 hrs, then treated with ethanol
as vehicle control (-Aldo) or 1 mM aldosterone (+Aldo) for 24 h
and analyzed by real-time RT-qPCR for expression of ENaC
subunits as positive controls for aldosterone upregulated genes (A),
and ENaC transcriptional regulators Dot1a, AF9 (as positive
controls of aldosterone downregulated genes), and AF17 (B). The
mRNA level of each gene was first normalized against b-actin
mRNA in the same sample, and set to 1 in the vehicle-treated cells.
In all cases, n=3. *: P,0.05 vs. ‘‘-Aldo’’. C. As in B except
mIMCD-3 cells were used. n=3. *: P,0.05 vs. ‘‘-Aldo’’.
(EPS)
Figure S3 AF17 knockdown had marginal effects on the
aldosterone-mediated induction of b and cENaC expres-
sion. Stably transfected M-1 cells depleting AF17 (see Fig. 2A)
were treated with ethanol as vehicle control (-Aldo) or aldosterone
(+Aldo, 1 mM), and analyzed by RT-qPCR for b and cENaC as in
Fig. 4F. In all cases, n=3. *: P,0.05 vs. vector.
(EPS)
Figure S4 Stably transfected M-1 cells developed mono-
layers with high resistance. A. M-1 cells stably transfected
with pCDNA3.1 (Vec) or pcDNA-hAF17 (AF17) were grown on
permeable filters and allowed to form confluent monolayers.
Shown are the resistances before the Isc measurement as shown in
Fig. 8. n=12 or 15 for each cell population, respectively. B. As in
A except that M-1 cells stably transfected with pSilencer-2.1-U6-
Hygro vector (Vec) or its derivative bearing AF17-specific
siRNA#11. n=14 and 17, respectively.
(EPS)
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